Hodgkin's Disease

Showing 1 - 25 of 90

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hodgkin's Disease Trial in Boston (Echo/Stress Echo)

Active, not recruiting
  • Hodgkin's Disease
  • Echo/Stress Echo
  • Boston, Massachusetts
  • +1 more
Mar 28, 2022

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus

Active, not recruiting
  • Acute Myelogenous Leukemia
  • +10 more
  • Atlanta, Georgia
  • +2 more
Feb 9, 2022

Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in

Completed
  • Hodgkin's Disease
    • Louisville, Kentucky
      Norton Cancer Institute
    Dec 14, 2021

    Lymphoma, Hodgkin's Disease, Relapse Trial in Houston (TGFbeta resistant LMP-specific CTLs)

    Active, not recruiting
    • Lymphoma
    • +3 more
    • TGFbeta resistant LMP-specific CTLs
    • Houston, Texas
    • +1 more
    Dec 8, 2021

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Winston-Salem

    Recruiting
    • Acute Myelogenous Leukemia
    • +9 more
      • Winston-Salem, North Carolina
        Wake Forest Baptist Health
      Nov 23, 2021

      HIV, Hodgkin's Disease Trial in United States (Vinblastine sulfate, Dacarbazine, Filgrastim)

      Completed
      • HIV Infections
      • Hodgkin's Disease
      • Vinblastine sulfate
      • +4 more
      • Birmingham, Alabama
      • +7 more
      Oct 26, 2021

      CD20+, B-cell Lymphomas, Mantle Cell Lymphoma, Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) Trial in Baltimore

      Completed
      • CD20+, B-cell Lymphomas
      • +5 more
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Oct 4, 2021

      Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic Trial in Belgium (Mesenchymal stem

      Terminated
      • Leukemia, Myeloid, Acute
      • +8 more
      • Mesenchymal stem cells
      • Isotonic solution
      • Edeghem, Antwerpen, Belgium
      • +9 more
      Aug 31, 2021

      Non-Hodgkin's Lymphoma and Hodgkin's Disease

      Recruiting
      • Lymphoma, Non-Hodgkin
      • Hodgkin's Disease
        • Stanford, California
          Stanford University School of Medicine
        Aug 2, 2021

        Multiple Myeloma, Non-hodgkin's Lymphoma, Hodgkin's Disease Trial in Stony Brook (TG-0054)

        Completed
        • Multiple Myeloma
        • +2 more
        • Stony Brook, New York
          Stony Brook University Hospital
        Apr 14, 2021

        Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute Trial in Minneapolis (biological, drug, radiation)

        Terminated
        • Leukemia, Myeloid, Chronic
        • +8 more
        • Stem Cell Transplant
        • +5 more
        • Minneapolis, Minnesota
          Masonic Cancer Center, University of Minnesota
        Dec 31, 2020

        Hodgkin's Disease, Non-Hodgkin's Lymphoma Trial in New York (Vorinostat, Niacinamide, Etoposide)

        Completed
        • Hodgkin's Disease
        • Non-Hodgkin's Lymphoma
        • New York, New York
          Center for Lymphoid Malignancies at CUMC
        Nov 5, 2020

        Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

        Completed
        • Related Donors Donating PBSC to a Family Member
        • +7 more
        • Tampa, Florida
        • +11 more
        Sep 3, 2020

        Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (CD3/CD28 Activated

        Terminated
        • Chronic Myelogenous Leukemia
        • +7 more
        • CD3/CD28 Activated T cells
        • Philadelphia, Pennsylvania
          University of Pennsylvania
        Aug 12, 2020

        Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC

        Completed
        • Acute Myelogenous Leukemia
        • +3 more
        • Infusion of one MPC expanded cord unit and one unexpanded cord unit
        • Infusion of two unexpanded cord blood units.
        • Miami, Florida
        • +8 more
        Jun 25, 2020

        Non-Hodgkin's Lymphoma, Hodgkin's Disease Trial in Russian Federation, United States (SB-743921)

        Completed
        • Non-Hodgkin's Lymphoma
        • Hodgkin's Disease
        • Hackensack, New Jersey
        • +7 more
        Jan 9, 2020

        Blood Cancer, Leukemia, GVHD Trial in Stanford (non-myeloablative hematopoietic cell transplantation, Anti-Thymocyte Globulin,

        Completed
        • Blood Cancer
        • +7 more
        • non-myeloablative hematopoietic cell transplantation
        • +8 more
        • Stanford, California
          Stanford University School of Medicine
        Nov 17, 2019

        MDS, AML, Solid Tumors Trial in United States (azacitidine)

        Completed
        • MDS
        • +5 more
        • Berkeley, California
        • +10 more
        Nov 6, 2019

        Hematological Malignancies, Leukemia, Lymphoma Trial in Philadelphia (Matched Sibling Allogeneic Transplantation)

        Completed
        • Hematological Malignancies
        • +4 more
        • Matched Sibling Allogeneic Transplantation
        • Philadelphia, Pennsylvania
          Thomas Jefferson University
        Sep 27, 2019

        Women Treated With Mediastinal Irradiation for Hodgkin's Disease

        Completed
        • Breast Cancer
        • Hodgkin's Disease
        • breast MRI
        • Mammogram
        • Boston, Massachusetts
        • +2 more
        Apr 30, 2019

        Lymphoma, Hodgkin's Disease Trial in Houston (Melphalan, Ara-C, VP-16)

        Completed
        • Lymphoma
        • Hodgkin's Disease
        • Houston, Texas
        • +1 more
        Nov 29, 2018

        Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (fludarabine/busulfan, fludarabine/

        Completed
        • Acute Myeloid Leukemia
        • +10 more
        • Chicago, Illinois
          University of Illinois at Chicago Medical Center
        Oct 9, 2018

        Hodgkin's Disease, Lymphoma Trial (Alemtuzumab (Campath-1H))

        Withdrawn
        • Hodgkin's Disease
        • Lymphoma
        • Alemtuzumab (Campath-1H)
        • (no location specified)
        Nov 6, 2018

        Hodgkin's Disease Trial in Baltimore (I-131 Tositumomab therapeutic regimen)

        Completed
        • Hodgkin's Disease
        • I-131 Tositumomab therapeutic regimen
        • Baltimore, Maryland
          Johns Hopkins Medical Institutions
        Jul 31, 2018